Industry & Policy News

[FiercePharma] Following a slew of cell therapy biotech team-ups, AstraZeneca is taking manufacturing into its own hands. The British pharma announced it will plug $300 million into a new facility in Rockville, Maryland, to launch its cell therapy platforms in the US for cancer trials and future commercial supply.

[Nature News] China and the United States will once again probably delay the renewal of a decades-old pact to cooperate on science and technology. The two nations have been negotiating for the past six months, but need more time to settle new terms and conditions requested by both sides, sources tell Nature.

[The Sun] University of Nottingham Malaysia associate professor Dr. Ho Weang Kee has been granted a Wellcome Trust Career Development Award amounting to RM11.3 million to be utilised to advance groundbreaking breast cancer risk stratification and communication techniques specifically tailored for diverse Asian populations.

[Nature News] A research-technology firm has developed a new approach to help identify journal articles that originate from paper mills — companies that churn out fake or poor-quality studies and sell authorships.

[Case Western Reserve University (EurekAlert)] With a new $2 million federal grant, a researcher with the Case Western Reserve University School of Medicine will lead a team to further explore preliminary findings of an effective treatment for colorectal and possibly other cancers.

[Monah University] Monash Biomedicine Discovery Institute (BDI) researcher Dr Lochlan Fennell has been awarded $100,000 over 12 months by Cure Cancer to investigate the possibility of restoring the youthfulness of the cells that cause bowel cancer.